Enigmatig (EGG) Current Deferred Revenue (2024 - 2025)
Enigmatig (EGG) recorded quarterly Current Deferred Revenue of $765.2 billion in Q3 2025, down 21.31% quarter-over-quarter from $972.5 billion in Q1 2025, and down 27.05% on a YoY basis from $1048.9 billion in Q3 2024.
Enigmatig (EGG) Current Deferred Revenue (2024 - 2025) Analysis & Trends
Enigmatig's Current Deferred Revenue history runs 2 years deep, the most recent figure standing at $765.2 billion for Q3 2025.
- In Q3 2025, Current Deferred Revenue fell 27.05% year-over-year to $765.2 billion; the TTM figure through Sep 2025 stood at $765.2 billion (down 27.05% YoY), while the FY2025 annual figure was $765.2 billion, down 27.05% from the prior year.
- Current Deferred Revenue was $765.2 billion for Q3 2025 at Enigmatig, down from $972.5 billion in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $1048.9 billion in Q3 2024 to a low of $765.2 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Verisk Analytics | 24.65 Bn | 24.13 Bn | 546.00 Mn |
| 2 | Equifax | 20.23 Bn | 20.17 Bn | 881.80 Mn |
| 3 | Booz Allen Hamilton Holding | 9.63 Bn | 8.90 Bn | 1.50 Bn |
| 4 | Fti Consulting | 4.78 Bn | 4.58 Bn | 306.83 Mn |
| 5 | Huron Consulting | 1.88 Bn | 1.85 Bn | 143.61 Mn |
| 6 | ICF International | 1.30 Bn | 1.25 Bn | 166.86 Mn |
| 7 | Cra International | 954.07 Mn | 921.58 Mn | 55.95 Mn |
| 8 | SBC Medical Group Holdings | 308.99 Mn | 159.92 Mn | 28.93 Mn |
| 9 | Roma Green Finance | 302.57 Mn | 299.88 Mn | - |
| 10 | Enigmatig | 163.65 Mn | -13,205.84 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 765.23 Bn |
| Mar 31, 2025 | 972.49 Bn |
| Sep 30, 2024 | 1,048.93 Bn |